By Dr Preeyaporn Srasuebkul

Conference Presentations

joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2016, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.3512

Heintze T; Srasuebkul P; Trollor J, 2016, 'Too much of a good thing?: Exploring the meaning of statistical significance, population inference and omitted variable bias when using large administrative data samples', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383462000285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Srasuebkul P; Ward R, 2013, 'HER2 POSITIVE EARLY BREAST CANCER (HER2EBC): AN AUSTRALIAN PATTERN OF CARE STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Srasuebkul P; Drew A; Chen K; Ward R; Pearson S-A, 2011, 'Cardiotoxic Cancer Therapies in Australia: Which Patients Are Assessed for Cardiac Function?', Vol. 20, pp. S248 - S248, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page